[Testicular germ cell tumours: descriptive study of 13 years of experience in the health care area of Badajoz]
- PMID: 17718207
- DOI: 10.4321/s0004-06142007000500005
[Testicular germ cell tumours: descriptive study of 13 years of experience in the health care area of Badajoz]
Abstract
Objectives: To describe the incidence of germ cell testicular tumors in our Center, their characteristics and therapy results.
Methods: Retrospective study of 66 cases of germ cell testicular tumors diagnosed in the Health Area of Badajoz between 1993 and 2005.
Results: Mean age of the time of diagnosis was 32 years (range 16-80 years), presenting a younger age patients with non seminomatous germ cell tumors (NSGCT) (mean age 30 years). 86.5% of the patients did not have risk factors associated with the diagnosis of germ cell testicular tumor. Testicular mass was the most frequent symptom, and a higher proportion of tumors were located in the left testicle (51.5%). Non seminomatous germ cell tumors were the most frequent histological type (64.8%). Stage I (72%) was the most frequent stage in the group of seminomatous tumors, in comparison with 68.5% of non seminomatous tumors. Stages II-III appeared in 34.4% of the NSGCT and 28% of seminomatous, having worse prognosis. 92% of the patients received adjuvant treatment with chemotherapy and/or radiotherapy, and curative surgery was the only treatment in the remainder 8%. Residual mass surgery was undertaken in five patients (stages IIa, IIc and IIIa). Eight of the 66 cases were lost for follow-up. Fifty-three of the 58 patients with follow-up are disease-free, 18 of them with more than five years of follow-up.
Conclusions: An increased incidence of germ cell testicular tumors have been verified over last years, mainly NSGCT Nevertheless, the diagnosis of advanced stages of the disease has diminished in favour of initial stages, which have a better prognosis for the patient. Oncologycal treatment protocols have high cure rates, although a long-term follow-up is needed due to the natural history of these tumors.
Similar articles
-
[Urologic treatment of testicular germ cell cancer].Arch Esp Urol. 2002 Oct;55(8):927-36. Arch Esp Urol. 2002. PMID: 12455283 Review. Spanish.
-
[Clinical presentation of testicular germinal cancer].Arch Esp Urol. 2002 Oct;55(8):915-22. Arch Esp Urol. 2002. PMID: 12455282 Review. Spanish.
-
Clinical presentation features of testicular cancer in public hospitals in the Autonomous Community of Madrid, Spain.Actas Urol Esp. 2015 Jan-Feb;39(1):2-7. doi: 10.1016/j.acuro.2014.03.009. Epub 2014 Sep 7. Actas Urol Esp. 2015. PMID: 25204991 English, Spanish.
-
Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.Eur J Cancer Care (Engl). 2010 Nov;19(6):827-32. doi: 10.1111/j.1365-2354.2009.01123.x. Eur J Cancer Care (Engl). 2010. PMID: 19708949
-
Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.Med Oncol. 2019 Feb 6;36(3):28. doi: 10.1007/s12032-019-1252-6. Med Oncol. 2019. PMID: 30725328
Cited by
-
Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First Presentation.Urol Int. 2018;100(4):409-419. doi: 10.1159/000488284. Epub 2018 Apr 12. Urol Int. 2018. PMID: 29649815 Free PMC article.
MeSH terms
LinkOut - more resources
Medical